Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT02055196
What this trial is testing

Genetically Modified Stem Cells and Irinotecan Hydrochloride in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+3 more
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00004024
What this trial is testing

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
Barbara Ann Karmanos Cancer Institute 60
Early research (Phase 1)Study completedNCT00704080
What this trial is testing

XL765 (SAR245409) in Combination With Temozolomide With and Without Radiation in Adults With Malignant Gliomas

Who this might be right for
Mixed GliomasMalignant GliomasGlioblastoma Multiforme
Sanofi 54
Early research (Phase 1)Study completedNCT01682746
What this trial is testing

Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 5
Testing effectiveness (Phase 2)Study completedNCT01520870
What this trial is testing

Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.

Who this might be right for
GlioblastomaBrain Tumor, Recurrent
Grupo Español de Investigación en Neurooncología 49
Early research (Phase 1)Active Not RecruitingNCT04323046
What this trial is testing

Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults

Who this might be right for
GlioblastomaMalignant GliomaRecurrent Glioblastoma+3 more
Sabine Mueller, MD, PhD 9
Testing effectiveness (Phase 2)Study completedNCT00499473
What this trial is testing

Sunitinib in Treating Patients With Recurrent Malignant Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Diffuse AstrocytomaAdult Giant Cell Glioblastoma+5 more
National Cancer Institute (NCI) 31
Not applicableStudy completedNCT04730869
What this trial is testing

Metabolic Therapy Program In Conjunction With Standard Treatment For Glioblastoma

Who this might be right for
Glioblastoma
Waikato Hospital 18
Testing effectiveness (Phase 2)Ended earlyNCT00730262
What this trial is testing

Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Thallion Pharmaceuticals 40
Very early researchStudy completedNCT05432375
What this trial is testing

Study of Tinostamustine for Adjuvant Treatment of Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Mundipharma Research Limited 10
Testing effectiveness (Phase 2)Study completedNCT03849105
What this trial is testing

131I-IPA and Concurrent XRT in Recurrent GBM

Who this might be right for
Glioblastoma Multiforme
Telix Pharmaceuticals (Innovations) Pty Limited 10
Not applicableEnded earlyNCT02175745
What this trial is testing

18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas

Who this might be right for
Adult Anaplastic EpendymomaAdult Anaplastic OligodendrogliomaAdult Brain Stem Glioma+54 more
Erik Mittra 2
Testing effectiveness (Phase 2)Study completedNCT02926222
What this trial is testing

Regorafenib in Relapsed Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Istituto Oncologico Veneto IRCCS 119
Testing effectiveness (Phase 2)Active Not RecruitingNCT05986851
What this trial is testing

Azeliragon in MGMT Unmethylated Glioblastoma

Who this might be right for
Glioblastoma
Cantex Pharmaceuticals 30
Testing effectiveness (Phase 2)Study completedNCT00967330
What this trial is testing

Avastin (Bevacizumab) and Irinotecan Versus Temozolomide Radiochemistry in Patients With Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Hoffmann-La Roche 182
Testing effectiveness (Phase 2)Ended earlyNCT01778530
What this trial is testing

TRC105 for Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
National Cancer Institute (NCI) 2
Not applicableAvailableNCT04091295
What this trial is testing

BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Who this might be right for
Pancreatic CancerOsteosarcomaMPNST (Malignant Peripheral Nerve Sheath Tumor)+6 more
Aveni Foundation
Not applicableLooking for participantsNCT06954636
What this trial is testing

Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study

Who this might be right for
Glioblastoma Multiforme, AdultGlioblastoma or GliosarcomaGlioblastoma, Adult
Sied Kebir 128
Early research (Phase 1)Study completedNCT02227901
What this trial is testing

Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT02498665
What this trial is testing

DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesGlioblastoma Multiforme+6 more
Sumitomo Pharma America, Inc. 24
Next Page